Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;6(4):409-417.
doi: 10.1016/j.imr.2017.08.006. Epub 2017 Sep 6.

Current status and future prospects of research and development operations in traditional and complementary and alternative medicine manufacturing small- and medium-sized enterprises: a 2014 company-based survey

Affiliations

Current status and future prospects of research and development operations in traditional and complementary and alternative medicine manufacturing small- and medium-sized enterprises: a 2014 company-based survey

Miyoung Ahn et al. Integr Med Res. 2017 Dec.

Abstract

Background: Small- and medium-sized enterprises (SMEs) have played key roles in the economic growth and technical innovation of traditional and complementary and alternative medicine (T&CM). Research and development (R&D) are critical activities for industrial progress. This study aimed to characterize the current status of SME R&D activities and to explore manufacturers' perceptions of R&D expansion.

Methods: Records of the distribution of T&CM SMEs and R&D resources detailed in the 2014 Statistics of Korea T&CM Industries survey, a previously conducted survey on the industrial status of the T&CM field, were reviewed. Data on the perceptions of R&D activities were investigated through a company-based survey covering 285 T&CM-manufacturing SMEs.

Results: Greater than 99% of the 13,636 T&CM manufacturers at the time of the study were SMEs employing less than 50 workers. Natural cosmetics manufacturing SMEs (NC SMEs) had the highest R&D expenditures. NC SMEs rely heavily on internal R&D operations, which may contribute to their strong need for R&D collaboration with public research institutions and expanded T&CM-promoted R&D programs. "Digestive system disorders" are the main target diseases for current herbal and dietary supplement manufacturing SMEs and herbal medicine manufacturing SMEs. These SMEs tend to view their own product-related business as a priority for future R&D investment.

Conclusion: This study represents the first attempt to assess SME perceptions of R&D activities. The findings herein can inform the design of sustainable programs that support R&D by reducing the gaps between the perspectives of T&CM product makers and policymakers.

Keywords: R&D; SME; South Korea; T&CM; survey.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Current R&D modes in T&CM SMEs. SMEs represent manufacturers employing less than 50 workers. HDS SMEs, herbal and dietary supplement manufacturing SMEs; HM SMEs, herbal medicine manufacturing SMEs; MD SME, T&CM-related medical device manufacturing SMEs; NC SMEs, and natural cosmetics manufacturing SMEs; R&D; research and development; SMEs, small- and medium-sized enterprises; T&CM, traditional and complementary and alternative medicine.
Fig. 2
Fig. 2
Potential target diseases of currently manufactured products. Disease categories are based on the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), with modifications (World Health Organization, 1992). The Roman numerals in parentheses indicate the relevant ICD-10 codes. *The term “Malignancies” was denoted as “anticancer drug” on the Korean version of the questionnaire. HDS, herbal and dietary supplement; HM, herbal medicine; MD, T&CM-related medical device; NC, natural cosmetics; SMEs, small- and medium-sized enterprises; T&CM, traditional and complementary and alternative medicine.

References

    1. Van Zyl A., Amadi-Echendu J., Bothma T.J.D. Nine drivers of knowledge transfer between universities and industry R&D partners in South Africa. S Afr J Inf Manage. 2007;9:1–22.
    1. Wang M.-Y. Exploring potential R&D collaborators with complementary technologies: the case of biosensors. Technol Forecast Soc Change. 2012;79:862–874.
    1. Lichtenthaler U. Open innovation in practice: an analysis of strategic approaches to technology transactions. IEEE Trans Eng Manage. 2008;55:148–157.
    1. Hagedoorn J. Inter-firm R&D partnerships: an overview of major trends and patterns since 1960. Res Policy. 2002;31:477–492.
    1. Arranz N., de Arroyabe J.C.F. Joint R&D projects: experiences in the context of European technology policy. Technol Forecast Soc Change. 2006;73:860–885.

LinkOut - more resources